An update on targets for treating osteoarthritis pain: NGF and TRPV1

Explore this paper's citation graph

Summary

An update on the current clinical and preclinical studies targeting two pathways for treating OA pain: the nerve growth factor (NGF) pathway and the transient receptor potential vanilloid-1 (TRPV1) pathway is given.

Type
article
Published
2020-05-06
Cited by
19
References
80
Access
Open access

Keywords

TRPV1, Osteoarthritis, Medicine, Physical medicine and rehabilitation, Neuroscience

References

Cited by

Related papers